Main Article Content
Abstract
Infection with the hepatitis C virus (HCV) is a worldwide problem. Patients with chronic HCV infection who are non-responders to standard therapy represent a growing population within the HCV epidemic.Novel, more efficient and tolerable therapies are urgently needed. This review discusses the recent results showing that targeting miR-122, a micro-ribonucleic acid (MicroRNA) that enhances HCV replication, is a new anti-HCV therapy with a high barrier to resistance.
Keywords
Hepatitis C virus
MicroRNAs
Interferon
Liver
Infection
Therapy
Article Details
How to Cite
Said, E. A. (2010). The Need for New Anti-Hepatitis C Virus Therapeutic Strategies : Targeting the cellular micro-ribonucleic acids?. Sultan Qaboos University Medical Journal, 10(3), 312–317. Retrieved from https://journals.squ.edu.om/index.php/squmj/article/view/1518